Massachusetts Financial Services
KYMR icon

Massachusetts Financial Services’s Kymera Therapeutics KYMR Stock Holding History

Massachusetts Financial Services’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.8M Buy
233,713
+24,708
+12% +$2.12M 0.01% 613
2026
Q1 		$17.4M Sell
209,005
-80,399
-28% -$6.37M 0.01% 665
2025
Q4 		$22.5M Sell
289,404
-145,610
-33% -$9.83M 0.01% 629
2025
Q3 		$24.6M Sell
435,014
-52,947
-11% -$2.39M 0.01% 602
2025
Q2 		$21.3M Buy
487,961
+67,916
+16% +$2.34M 0.01% 609
2025
Q1 		$11.5M Buy
420,045
+555
+0.1% +$20.2K ﹤0.01% 650
2024
Q4 		$16.9M Sell
419,490
-33,887
-7% -$1.53M 0.01% 620
2024
Q3 		$21.5M Buy
453,377
+47,507
+12% +$2.1M 0.01% 586
2024
Q2 		$12.1M Buy
405,870
+10,731
+3% +$372K ﹤0.01% 625
2024
Q1 		$15.9M Sell
395,139
-67,536
-15% -$2.42M ﹤0.01% 599
2023
Q4 		$11.8M Sell
462,675
-858
-0.2% -$15.3K ﹤0.01% 614
2023
Q3 		$6.44M Buy
463,533
+86,585
+23% +$1.74M ﹤0.01% 645
2023
Q2 		$8.67M Buy
376,948
+37,801
+11% +$1.08M ﹤0.01% 617
2023
Q1 		$10M Buy
+339,147
New +$10.9M ﹤0.01% 611

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Massachusetts Financial Services's KYMR Position: Q2 2026 in Review

Massachusetts Financial Services increased its Kymera Therapeutics (KYMR) stake by 12% in Q2 2026, buying an estimated $2.12M and bringing the position to 233,713 shares worth $26.8M. The position accounts for 0.01% of the portfolio, ranked #613.

Massachusetts Financial Services first reported a position in KYMR in Q1 2023 and has held it in 14 quarters since. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Massachusetts Financial Services held 233,713 shares of Kymera Therapeutics worth $26.8M as of Q2 2026.
  • Massachusetts Financial Services bought 24,708 Kymera Therapeutics shares in Q2 2026, an estimated $2.12M.
  • Kymera Therapeutics made up 0.01% of Massachusetts Financial Services's portfolio in Q2 2026, its #613 holding.
  • Massachusetts Financial Services first reported a position in Kymera Therapeutics in Q1 2023 and has held it in 14 quarters since.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Massachusetts Financial Services's 13F filing for Q2 2026, filed 3 Aug 2026.